AlphaMol
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- Undisclosed
Investors
- 5
About AlphaMol
Established in 2020 and based in Shenzhen, China, ALPHAMOL SCIENCE LTD, trading as AlphaMol, is a biopharmaceutical company incubated by the Shenzhen Institute of Advanced Technology under the Chinese Academy of Sciences, focusing on AI-assisted new drug research and development. The company has factories in Basel, Switzerland, as well as in Shanghai and Shenzhen, China. In addition, it has four major research departments including: Computational Drug Discovery, Medicinal Chemistry, Cell Biology and Biochemistry, and Pharmacology. The founding partners of this company, academics Horst Vogel and Dr. Shuguang Yuan, have both been named to the top 2% of the world's leading scientists. The science and technology team participated in the global GPCR-DOCK computer predictive modeling competition and beat Google AlphaFold2 in the prediction of the spatial structure of the relevant target, and won second, third, and fifth place in the world. The company's self-developed products include a biochip to test G protein-coupled receptor proteins (GPCR), a biochip to test cellular electrophysiology, and a biochip to track single-molecule cells. It has also developed a GPCR (G-protein-coupled receptors) drug discovery platform that enables efficient screening, design and optimization of drug molecules and rapid access to clinical candidate molecules. In addition, its product pipeline includes bifunctional anticancer drugs, infection drugs, low-side effect painkillers, cancer drugs and metabolic drugs. The company generates revenue by developing and providing AI-assisted drug and other related products.
Who invested in AlphaMol
5 investors across 2 rounds
See all investors in AlphaMol
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AlphaMol
Who invested in AlphaMol?
AlphaMol has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AlphaMol raised?
AlphaMol has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AlphaMol last raise money?
AlphaMol's most recent round on record is a Series B, in Nov 2025.
What does AlphaMol do?
Established in 2020 and based in Shenzhen, China, ALPHAMOL SCIENCE LTD, trading as AlphaMol, is a biopharmaceutical company incubated by the Shenzhen Institute of Advanced Technology under the Chinese Academy of Sciences, focusing on AI-assisted new drug research and development.
Where is AlphaMol headquartered?
AlphaMol is headquartered in Shenzhen, China.
Which VCs invest in companies like AlphaMol?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at AlphaMol's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like AlphaMol? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.